Overview

A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Status:
Withdrawn

Trial end date:
2016-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and effectiveness of golimumab for the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis among Filipino patients.

Details

Lead Sponsor:

Janssen Pharmaceutica

Treatments:

Antibodies, Monoclonal
Golimumab